ANIMAL GROWTH PROMOTERS PERFORMANCE ENHANCERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Animal Growth Promoters Performance Enhancers Market Size and Trends

Global animal growth promoters performance enhancers market is estimated to be valued at USD 17.33 Bn in 2024 and is expected to reach USD 25.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

The animal growth promoters performance enhancers market is expected to witness positive growth over the forecast period. The rising consumption of meat and meat products is surging the demand for animal growth promoters to enhance the productivity of livestock. Various growth promoters such as antibiotics, prebiotics, probiotics, and symbiotics are gaining traction. Moreover, ban on antibiotic growth promoters in various countries such as Nambia has shifted the focus on alternatives like prebiotics and probiotics. The probiotics segment is expected to grow at a higher rate during the forecast period. However, stringent regulations pertaining to the use of growth promoters in animal feed could hamper the market growth.

Market Driver – Increasing Demand for Meat and Dairy Products

The consumption of meat and dairy products has increased substantially across both developing and developed nations owing to rising incomes, population growth, and urbanization. As populations continue to grow globally and become wealthier, people are consuming more meat, poultry, fish, eggs, and dairy on a per capita basis. This boom in the consumption of animal protein has spurred intensive farming practices to ramp up the meat production to meet demand. Farmers are under constant pressure to raise livestock that grows faster, bigger, and require less feed. By facilitating more efficient growth, animal growth promoters and performance enhancers help satisfy the growing worldwide appetite for animal protein while maximizing profit margins for producers.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

The global population is projected to reach almost 10 billion by 2050, According to data published by World Bank, placing unprecedented pressure on agriculture and food systems. At the same time, arable land resources are limited and climate change pose challenges. Meat production is also coming under scrutiny due to environmental impacts. In this scenario, it is crucial for livestock farmers to maximize yields from their animals while coping with constraints. Animal growth promoters and performance enhancers provide solutions to boost output per animal without demanding more land or water resources. Their use ensures high productivity levels year after year even as operating costs rise. Furthermore, market forces like intense competition and price wars in the meat industry place constant pressure on producers to improve efficiency. Growth promoters help farms and meat suppliers enhance turnover, meet delivery commitments, and achieve quality specifications demanded by food retailers and restaurant chains.

To learn more about this report, Request sample copy

Stringent regulations in the European Union and other regions have banned the non-therapeutic use of antibiotics as growth promoters in animals. This is negatively impacting revenue growth for many pharmaceutical companies. Additionally, consumers are increasingly seeking meat produced from animals that are raised without antibiotics or hormones.

Market Opportunities – Increasing Preference for Antibiotic-free Meat

The animal growth promoters and performance enhancers market presents various opportunities owing to the rising push for antibiotic-free meat is boosting the demand for all-natural alternatives like prebiotics, probiotics, enzymes, organic acids, and phytochemicals. Emerging economies with rising meat consumption and limited regulations represent large potential markets. Manufacturers are investing in R&D to develop innovative natural products that are more effective and economical substitutes for traditional growth promoters.

Discover high revenue pocket segments and roadmap to it: Request sample copy

Product segment is sub-segmented into antibiotic growth promoters, beta-agonist growth promoter, feed enzymes growth promoter, probiotic growth promoter, and others. Antibiotic growth promoters segment is expected to hold 34.5% of the market share in 2024 owing to their widespread historical use and proven effectiveness in promoting growth. However, concerns over antibiotic resistance have led to their restricted usage in many countries. Antibiotic growth promoters work by exploiting the same mechanism as medically important antibiotics, their use in animal agriculture increases the spread of antibiotic resistant bacteria. With growing scientific evidence and regulatory pressures linking non-therapeutic use of antibiotics to emergence of superbugs, producers are compelled to move away from traditional antibiotic growth promoters. Alternative growth promoter categories like beta-agonists, prebiotics, probiotics and feed enzymes are seeing increased adoption as safe substitutes. Beta-agonists function by redirecting nutrients away from digestive processes and towards growth and muscle development. Prebiotics and probiotics promote beneficial bacteria in the gut microbiome to enhance digestive health and nutrient absorption. Feed enzymes help break down plant-based feed, liberating trapped nutrients, and enabling better feed conversion rates.

Insights, By Animal Type: Pork Production Focuses Growth Promoter Efforts on Porcine Species

Animal type segment is sub-segmented into porcine, livestock, equine, aquaculture, and others. Porcine segment is expected to hold 27.8% of the market share in 2024 owing to pigs being one of the most widely and intensively reared livestock globally. As efficient converters of plant-based feed into meat, even marginal improvements in growth and feed efficiency can translate into large economic benefits for pork producers. Additionally, consumers increasingly demand safe, affordable, and sustainably produced pork products. Growth promoters are extensively used in pig production to meet these goals. Antibiotics have been widely used historically in weaner pig diets to overcome stresses of weaning and mixing as well as promote uniform growth. Alternatives like prebiotics, probiotics, phytogenics, and farm management practices are increasingly adopted to substitute these applications. Sows and boars are also fed functional ingredients and feed additives to optimize reproductive performance. Addressing both pre- and post-weaning challenges through strategic use of effective and residue-free growth promoters helps maximize productivity and welfare within this high-volume species. Enhancing growth rates and feed efficiency allows producers to achieve target slaughter weights earlier. This improves farm output and income while also optimizing pork quality. With pork consumption on the rise globally, growth promoter use enables sustainable intensification to meet rising demand through the same farm footprint. This makes porcine production highly reliant on growth promoters compared to other livestock species.

Insights, By Nature of Chemicals: Microbial-Based Growth Promoters Dominate Product Arsenal

Nature of chemicals segment is sub-segmented into microbial, prebiotics, probiotics, and others. Microbial segment is expected to hold 32.7% of the market share in 2024 owing to their natural profile appealing to producers as well as end consumers. Microbial products encompass various prebiotics, probiotics, phytogenics, and other bioactive ingredients that positively modulate the gut microbiome. Acting as non-antibiotic growth promoters, these products display diverse modes of action spanning microbial balance, gut health, feed digestion, and nutrient absorption. The strategic inclusion of functional microbial ingredients helps address sub-clinical challenges which cumulatively impacts the growth performance. Their application areas range from weaned pigs and poultry to ruminants, shrimp, and fish aquaculture. Non-antibiotic microbial growth promoters are particularly suited for replacing in-feed antibiotics due to a smooth post-ban transition. Not involving the same resistance mechanisms as antibiotics also assures both food safety and responsible antibiotic use. A diverse range of proprietary probiotic strains, prebiotic substrates, and herbal extracts further allow customized solutions across production systems and geographies.

Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global animal growth promoters performance enhancers market and is anticipated to hold 36.6% of the market share in 2024 owing to a well-established livestock industry and strong focus on meat consumption. This provides them an advantage in terms of supply chain and strong distribution network within the region. The ban on hormone growth promoters by the U.S. Food and Drug Administration and the adoption of antibiotic-free meat have boosted the demand for alternative natural feed additives. Manufacturers are investing heavily in research and development to develop novel growth enhancers derived from plants and seaweeds. Such innovations are gaining popularity among farms looking to produce antibiotic residue-free meat. North American farms also have higher affordability and purchasing power allowing faster adoption of newer products.

The Asia Pacific region is emerging as the fastest growing regional market worldwide. Countries like Vietnam, Thailand, and Indonesia have seen enormous growth in the consumption of animal-based food products over the last decade due to rising incomes and population. This has propelled the need for higher farm efficiency and yields. However, traditionally farms in the region have relied on rudimentary practices and used fewer additives. Recently local manufacturers have entered this market understanding the lucrative growth opportunities. They are offering cost-effective products tailored to smallholder farms which is increasing adoption. Additionally, the booming aquaculture industry in the region dominated by shrimp production is boosting the sales of tailored aqua feed additives. Looking at the current growth trend, Southeast Asia seems well positioned to become one of the leaders in the global animal growth promoters performance enhancers market in the coming years.

Market Report Scope

Animal Growth Promoters Performance Enhancers Industry News

• On February 14, 2024, Blacksmith Medicines, Inc., a global biopharmaceutical company, and Zoetis, a global animal health company, announced a collaboration, to discover and develop novel antibiotics for animal health
• In October 2021, Cargill Incorporated, a global food corporation company, announced that it had launched Nutrena NatureWise formulas to boost the overall wellness, happiness, and productivity of backyard chicken. The natural essential oils contribute to the promotion of egg weight, size and production, enhanced palatability, and a fresh aroma direct from the bag.
• In June 2021, Novozymes A/S, a biotechnology company, announced a launch of ProAct 360, a second-generation protease, improvements in growth performance, along with improved matrix values for key amino acids and faster action. ProAct 360 helps feed producers to be more flexible in their selection and use of raw materials, reducing the industry’s reliance on soy and other major crops while at the same time helping to cut feed costs.

*Definition: The animal growth promoters performance enhancers market consists of pharmaceutical products, feed additives, and implants that are administered to livestock such as cattle, poultry, and pigs to boost their growth and development. These growth promoters enhance the feed utilization and increase the meat and milk production by stimulating protein synthesis and cell replication. Common growth enhancers are antibiotic growth promoters, prebiotics & probiotics, feed enzymes, hormones, and beta-agonists.

Market Segmentation

•  Product Insights (Revenue, USD Bn, 2019 - 2031)
  • Antibiotic Growth Promoters
  • Beta-Agonist Growth Promoter
  • Feed Enzymes Growth Promoter
  • Probiotic Growth Promoter
  • Others
•  Animal Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Porcine
  • Livestock
  • Equine
  • Aquaculture 
  • Others
•  Nature of Chemicals Insights (Revenue, USD Bn, 2019 - 2031)
  • Microbial
  • Prebiotics
  • Probiotics
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • BIOMIN Holding GmbH
  • Adisseo
  • DuPont
  • Intervet Inc.
  • Zoetis
  • Bayer AG
  • DSM
  • Erber AG
  • Novozymes A/S
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Elanco Animal Health Incorporated
  • Bupo Animal Health Pty Ltd
  • Novus International, Inc.
  • Alltech Corporation